Biblio Discovery — Demo Discovery Service

4 hasil untuk "Mathilde Doisy"

Menampilkan 1–4 · 0,42 detik · RSS

  1. Artikel Jurnal

    Ineffective behavioral rescue despite partial brain Dp427 restoration by AAV9-U7-mediated exon 51 skipping in mdx52 mice

    Ophélie Vacca; Amel Saoudi; Mathilde Doisy dkk.

    Molecular Therapy: Nucleic Acids, Vol. 36 No. 4 · 2025 · Inggris · DOAJ Scopus

    The mdx52 mouse model exhibits a common mutation profile associated with brain involvement in Duchenne muscular dystrophy (DMD), characterized by heightened anxiety, fearfulness, and impaired associative fear learning. Deletion of exon 52 disrupts the expression of two dystrophins found in the…

  2. Artikel Jurnal

    Improving angiogenesis ameliorates the efficacy of ASO-based exon skipping for the treatment of Duchenne muscular dystrophy

    Mathilde Blitek; Cécile Gastaldi; Mathilde Doisy dkk.

    Molecular Therapy: Nucleic Acids, Vol. 37 No. 1 · 2026 · Inggris · DOAJ Scopus

    Duchenne muscular dystrophy (DMD) is a severe X-linked disease caused by pathogenic variants in the DMD gene, resulting in the absence of functional dystrophin. Antisense oligonucleotide (ASO)-based therapies aim to restore the open reading frame and produce a truncated but functional dystrophin…

  3. Artikel Jurnal

    Partial restoration of brain dystrophin by tricyclo-DNA antisense oligonucleotides alleviates emotional deficits in mdx52 mice

    Amel Saoudi; Sacha Barberat; Olivier le Coz dkk.

    Molecular Therapy: Nucleic Acids, Vol. 32 · 2023 · Inggris · DOAJ Scopus

    The mdx52 mouse model recapitulates a frequent mutation profile associated with brain involvement in Duchenne muscular dystrophy. Deletion of exon 52 impedes expression of two dystrophins (Dp427, Dp140) expressed in brain, and is eligible for therapeutic exon-skipping strategies. We previously…

  4. Artikel Jurnal Teks lengkap

    Networking to Optimize Dmd exon 53 Skipping in the Brain of mdx52 Mouse Model

    Mathilde Doisy; Ophélie Vacca; Claire Fergus dkk.

    Biomedicines, Vol. 11 No. 12 · 2023 · Inggris · DOAJ Scopus

    Duchenne muscular dystrophy (DMD) is caused by mutations in the DMD gene that disrupt the open reading frame and thus prevent production of functional dystrophin proteins. Recent advances in DMD treatment, notably exon skipping and AAV gene therapy, have achieved some success aimed at alleviating…